Full-year report on Innate Pharma's liquidity contract with Gilbert Dupont

January 5, 2016 at 8:00 AM EST

Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at December 31, 2015:

  • 22,128 shares of Innate Pharma, and
  • 358,336.72 euros in cash

As a reminder, at June 30, 2015, the following assets appeared on the liquidity account:

  • 26,811 shares of Innate Pharma, and
  • 334,840.22 euros in cash